Patents for C07D 498 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms (21,960) |
---|
08/11/2005 | US20050176796 Tricyclic pyrazole derivatives, process for their preparation and their use as antitumor agents |
08/11/2005 | US20050176786 Anticancer agents; inhibit Abelson tyrosine kinase, Ron receptor tyrosine kinase, Met receptor tyrosine kinase, Fms-like tyrosine kinase-3, or p21-activated kinase-4; e.g. 3-substituted-5-(carbonylamino or sulfonamido)-1H-pyrazolo[3,4-d]thiazole |
08/11/2005 | US20050176706 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions and uses thereof |
08/11/2005 | US20050176703 Heterocyclic antiviral compounds |
08/11/2005 | US20050176702 1,8-Annelated quinoline derivatives substituted with carbon-linked triazoles as farnesyl transferase inhibitors |
08/11/2005 | US20050175660 Stents, catheters,by-pass graft; drug delivery; balloon overcoated with drugs |
08/11/2005 | CA2457459A1 Resolution of racemates of methyl alpha-5-(4,5,6,7-tetrahydro(3,2-c)thienopyridyl)-(2-chlorophenyl) acetate |
08/10/2005 | EP1560893A1 Photochromic compositions and light transmissible articles |
08/10/2005 | EP1560584A2 Fab i inhibitors |
08/10/2005 | EP1395570B1 Oxazin(thi)one compounds used as fungicides |
08/10/2005 | EP1345946B1 Macroheterocylic compounds useful as kinase inhibitors |
08/10/2005 | CN1653073A Substituted phenylacetic acids |
08/10/2005 | CN1653071A 10-(3-cyclopropylaminomethyl-1-pyrrolidinyl)pyridobenzoxazinecarboxylic acid derivative effective against resistant bacterium |
08/10/2005 | CN1214087C Novel red fluorescent material and organic electroluminescent device containing same |
08/10/2005 | CN1214009C antibacterial composition |
08/09/2005 | US6927232 Phenylethynyl and styryl derivatives of imidazole and fused ring heterocycles |
08/09/2005 | CA2095659C Heteroatoms-containing tricyclic compounds |
08/04/2005 | WO2005070941A1 Rifamycin imino derivatives effective against drug-resistant microbes |
08/04/2005 | WO2005070940A2 Rifamycin derivatives effective against drug-resistant microbes |
08/04/2005 | WO2005070938A1 Stable salts of olanzapine |
08/04/2005 | WO2005070906A1 Organic compounds |
08/04/2005 | WO2005070885A1 Bis bicyclic amides as vanilloid receptor ligands and their use in treatments of inflammatory and neuropatic pain |
08/04/2005 | WO2005069865A2 Pyrrolopyrimidine derivatives and analogs and their use in the treatment and prevention of diseases |
08/04/2005 | WO2005049735A3 A process for aqueous milling of quinacridone pigments |
08/04/2005 | US20050171142 New crystalline monohydrates and crystalline anhydrates of gaboxadol; suitable for oral dosage administration |
08/04/2005 | US20050171140 Prevent cholesterol biosynthesis; moderating blood serum lipid ; antidiabetic agents; obesity; hypotensive agents; osteoporosis; Alzheimer's disease; cardiovascular disorders; hormone replacement therapy |
08/04/2005 | US20050171122 Mitotic kinesin inhibitors |
08/04/2005 | US20050171100 Dehydrative cyclization of a 3,7-dihydroxy-1,5-diazacyclooctane compounds; one pot process with milder reaction conditions |
08/04/2005 | US20050171087 high affinity agonists; high specificity; side effect reduction; endometriosis; hormone dependent cancers, fertility control; dibenzo[b,f]pyrido[1,2-d][1,4] oxazepin, dibenzo[b,f]pyrido[1,2-d][1,4]thiazepim, dibenzo[b,f]pyrido[1,2-d][1,4]diazepin and dibenzo[c,f]pyrido[1,2-a]azepine derivatives |
08/04/2005 | US20050169993 Sustained-release formulation |
08/04/2005 | US20050167637 cycloquaterbenzoxazoles, cycloquaternaphthoxazoles, cycloquaterbenzimidazoles and cycloquaternaphthimidazoles, used in photoactive performance chemicals, such as charge generating compounds in organic light emitter diodes,as phase transfer catalysts, dispersants in pigments or optical recording media |
08/04/2005 | CA2553966A1 Vanilloid receptor ligands and their use in treatments |
08/04/2005 | CA2553009A1 Organic compounds |
08/03/2005 | EP1559717A2 Oxabispidine compounds useful in the treatment of cardiac arrythmias |
08/03/2005 | EP1558622A1 Method of purifying macrolides |
08/03/2005 | EP1558341A2 Transcription factor modulating compounds and methods of use thereof |
08/03/2005 | EP1558243A2 Tetrahydropyranyl cyclopentyl benzylamide modulators of chemokine receptor activity |
08/03/2005 | CN1649879A Non-steroidal progesterone receptor modulators |
08/03/2005 | CN1649878A 1-oxa-3-aza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the production thereof |
08/03/2005 | CN1649852A Method for extracting a macrolide from biomatter |
08/03/2005 | CN1649551A Drug-delivery endovascular stent and method for treating restenosis |
08/03/2005 | CN1213036C Novel amide derivatives |
08/02/2005 | US6924280 Dipeptide derivatives |
08/02/2005 | CA2321639C Bicyclo[2.2.1]heptanes and related compounds |
07/28/2005 | WO2005068473A1 Bicyclic pyrazolo-fused compounds as protein kinase modulators |
07/28/2005 | WO2005068472A1 Tricyclic benzazepine derivatives as squalene synthase inhibitors used for the treatment of cardiovascular diseases |
07/28/2005 | WO2005068466A1 Compounds useful in therapy |
07/28/2005 | WO2005067546A2 Pyrrolopyrimidine derivatives and analogs and their use in the treatment and prevention of diseases |
07/28/2005 | US20050165227 Antiproliferative agents; gene overexpression |
07/28/2005 | US20050165046 Bis-bicyclic amides and derivatives thereof and compositions containing them for the treatment of acute, inflammatory and neuropathic pain; 4-chloro-N-(2,3-dihydro-1,4-benzodioxin-6-yl)-7-(trifluoromethyl)-3-quinolinecarboxamide |
07/28/2005 | US20050165045 Compounds and methods |
07/28/2005 | US20050165029 Pyrrolopyrimidine derivatives and analogs and their use in the treatment and prevention of diseases |
07/28/2005 | US20050165003 Treating Alzheimer's Disease; 4-Chloro-N-(4-hydroxy-3-methoxy-benzyl)-N-(2-oxo-azepan-3-yl)-benzenesulfonamide for example; gamma secretase inhibitors; inhibition of beta-amyloid synthesis with minimal inhibition of Notch Signaling |
07/28/2005 | US20050164886 Herbicidal compositions |
07/28/2005 | CA2554382A1 Compounds useful in therapy |
07/28/2005 | CA2553202A1 Tricyclic benzazepine derivatives as squalene synthase inhibitors used for the treatment of cardiovascular diseases |
07/28/2005 | CA2547703A1 Bicyclic pyrazolo-fused compounds as protein kinase modulators |
07/27/2005 | EP1557421A1 Polymorphous forms of rifaximin as antibiotics |
07/27/2005 | EP1557420A1 Process for producing optically active sulfoxide |
07/27/2005 | EP1557418A1 Novel quinoxaline derivatives |
07/27/2005 | EP1557416A1 Oxazolidinone-quinolone hybrid antibiotics |
07/27/2005 | EP1557410A2 Bacterial gyrase inhibitors and uses thereof |
07/27/2005 | EP1557168A2 Biarylurea Derivatives |
07/27/2005 | EP1343766B1 Cyclization process step in the making of quinolones and naphthyridines |
07/27/2005 | CN1646537A Phosphorus-containing compounds & uses thereof |
07/27/2005 | CN1646502A Triazole derivatives as tachykinin receptor antagonists |
07/27/2005 | CN1646489A Delta1-pyrrolines and their use as pestcidal |
07/27/2005 | CN1212323C Process for synthesizing oxazole [4,5-b] pyridine-2-(3H) ketone |
07/27/2005 | CN1212317C Novel ester or amide derivatives |
07/26/2005 | US6921767 Such as (2-(4-(3-(1,4,5,6-Tetrahydropyrimidin-2-ylamino)prop oxy)phenyl) -cyclopropyl)acetic acid; for treating angiogenesis/osteoporosis/ humoral hypercalcemia/smooth muscle cell migration/atherosclerosis/arthritis |
07/26/2005 | US6921650 Recombinant methods and materials for producing epothilone and epothilone derivatives |
07/21/2005 | WO2005065779A1 Calcitonin gene related peptide receptor antagonists |
07/21/2005 | US20050159602 Method for synthesizing chiral bicyclic thiazolidine hydantoin |
07/21/2005 | US20050159596 Cyclic compounds and their use as complex ligands |
07/21/2005 | US20050159451 NMDA (N-methyl-D-aspartate) receptors; eg 6-(4-benzylpiperidin-1-carbonyl)-1,5-dihydro-oxazolo[4,5-f]indole-2-one |
07/21/2005 | US20050159436 Bicyclic heterocycles, pharmaceutical compositions containing these compounds, their use and processes for the preparation thereof |
07/21/2005 | US20050159416 Substituted urea derivatives activate the cardiac sarcomere by potentiating cardiac myosin; systolic heart failure including congestive heart failure; 1-[3-(1-Acetyl-piperidin-3-yloxy)-5-fluoro-phenyl]-3-(6-methoxy-pyridin-3-yl)-urea |
07/21/2005 | US20050159411 Bactericides for infrections in man |
07/21/2005 | US20050159408 Heating a reaction mixture of N-methylpiperazine and thienobenzodiazepine to 110 to 145 degrees C |
07/21/2005 | CA2549330A1 Calcitonin gene related peptide receptor antagonists |
07/20/2005 | EP1555267A1 2,3-DIHYDRO-6-NITROIMIDAZO 2,1-b OXAZOLES |
07/20/2005 | EP1554286A1 Fused heterocyclic isoxazoline derivatives and their use as anti-depressants |
07/20/2005 | EP1554285A1 Chemical intermediate |
07/20/2005 | EP1554260A1 Aryloxyalkylamine derivatives as h3 receptor ligands |
07/20/2005 | EP1553949A2 Pyrimidine-2,4-dione derivatives as matrix metalloproteinase inhibitors |
07/20/2005 | EP1385852B1 Compounds and methods for inhibiting mrp1 |
07/20/2005 | EP1011648B2 Combination of tyrosine kinase inhibitor and chemical castration to treat prostate cancer |
07/20/2005 | CN1642960A Substituted amino isoxazoline derivatives and their use as anti-depressants |
07/20/2005 | CN1642949A Bicyclic heterocyclic substituted phenyl oxazolidinone antibacterial, related compositions and methods |
07/20/2005 | CN1642924A Anxiolytic agents with reduced sedative and ataxic effects |
07/20/2005 | CN1642917A Non-peptide GnRH antagonists |
07/20/2005 | CN1642552A 4-(N-phenylamino)-quinazolines / quinolines as tyrosine kinase inhibitors |
07/20/2005 | CN1211374C Heterocyclic derivative, its preparation method and medicine compositioncontaining them |
07/20/2005 | CN1211373C 2,d-di (hetero-) arylamino (-oxy)-5-substituted pyrimidines as antineoplastic agents |
07/19/2005 | US6919450 Process for the preparation of benazepril |
07/19/2005 | US6919367 Substituted thioacetamides |
07/19/2005 | US6919362 For use as hypoglycaemic and hypolipidaemic agents |
07/19/2005 | US6919355 Amide derivatives as NMDA receptor antagonists |
07/19/2005 | US6919334 Antidepressant azaheterocyclymethyl derivatives of 4,5-dihydroimidazo[1,4,5-de][1,4]benzoxazine |
07/19/2005 | US6918958 Acid pigment dispersants and pigment preparations |